EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial‐Mesenchymal Transition Through the Notch Signalling Pathway

Wei Yu, Raj K Varma, Yiming Ma, Varun Chandra Boinpelly, Areej Khatri, Emma Gombos, Rakesh K Srivastava iD, Sharmila Shankar iD

Journal of Cellular and Molecular Medicine · 2026-05 · 30 (9)

DOI: 10.1111/jcmm.71158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 26.04.2026. Verfasst von Wei Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City VA Medical Center, Kansas City, Missouri, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Homeodomain Proteins, Epithelial-Mesenchymal Transition, Signal Transduction. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Department of Veterans Affairs Merit Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence and mortality of pancreatic cancer are steadily increasing worldwide, and the disease is projected to become the second leading cause of cancer‐related deaths by 2030. Pancreatic tumorigenesis is driven by multiple genetic alterations, underscoring the need to elucidate the molecular mechanisms underlying pancreatic carcinogenesis. In this context, the present study is the first to identify a novel oncogenic role for Engrailed 2 (EN2) in the initiation and progression of pancreatic cancer and to characterise its underlying molecular pathogenesis. Immunohistochemical analysis of a pancreatic cancer tissue microarray revealed significantly elevated EN2 expression in tumour tissues compared with adjacent normal tissues. Consistent with these findings, EN2 was markedly upregulated in human pancreatic cancer cell lines, but absent in normal pancreatic epithelial cells, and functional studies demonstrated that EN2 expression is oncogenic in pancreatic cancer. TCGA data further corroborated the significantly higher EN2 expression in pancreatic cancer tissues and showed that elevated EN2 levels are associated with poor overall survival. To define the biological significance of EN2, we investigated its role in promoting pancreatic cancer initiation and progression. Gain‐ and loss‐of‐function studies revealed that EN2 regulates key target genes involved in pluripotency, cell survival, and cell‐cycle progression, drug resistance, and epithelial–mesenchymal transition. Moreover, lentiviral‐mediated shRNA knockdown of EN2 suppressed pancreatic cancer cell proliferation, invasion, and metastasis in vitro and significantly inhibited tumour growth in a xenograft mouse model, in part by inhibiting Notch signalling. Taken together, these findings identify EN2 as a critical driver of pancreatic cancer initiation, progression, and metastasis, representing the first report of its oncogenic function in this malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHomeodomain ProteinsEpithelial-Mesenchymal TransitionSignal TransductionReceptors, NotchNerve Tissue ProteinsCarcinogenesisHumansAnimalsCell Line, TumorGene Expression Regulation, NeoplasticDisease ProgressionEngrailed 2 ProteinCell ProliferationMiceCell MovementFemaleMice, Nude

Stichwörter der Autor:innen

Bcl‐2EN2NanogOct4cMyccyclin D1notchpancreatic cancertransformation

Substanzen

Homeodomain ProteinsReceptors, NotchEngrailed 2 ProteinNerve Tissue Proteins

Autor:innen und Institutionen

  • Kansas City VA Medical Center, Kansas City, Missouri, USA.
  • Department of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
  • John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA.

ORCID-Profile: Rakesh K Srivastava, Sharmila Shankar

Förderung

  • BLRD VA
  • Department of Veterans Affairs Merit Award

Zitieren

APA

Yu, W., Varma, R. K., Ma, Y., Boinpelly, V. C., Khatri, A., Gombos, E., Srivastava, R. K., & Shankar, S. (2026). EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial‐Mesenchymal Transition Through the Notch Signalling Pathway. Journal of Cellular and Molecular Medicine, 30(9). https://doi.org/10.1111/jcmm.71158

Vancouver

Yu W, Varma RK, Ma Y, Boinpelly VC, Khatri A, Gombos E, et al. EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial‐Mesenchymal Transition Through the Notch Signalling Pathway. Journal of Cellular and Molecular Medicine. 2026;30(9). doi:10.1111/jcmm.71158

BibTeX
@article{Yu2026,
  author = {Yu, Wei and Varma, Raj K and Ma, Yiming and Boinpelly, Varun Chandra and Khatri, Areej and Gombos, Emma and Srivastava, Rakesh K and Shankar, Sharmila},
  title = {EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial‐Mesenchymal Transition Through the Notch Signalling Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {9},
  doi = {10.1111/jcmm.71158}
}
Kostenlos starten →